Paper20007267
Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
Bayer W and 7 others. J Virol, 2010. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection. Papers, record 20007267. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20007267
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoviridae | Major topic |
| Antigens, Viral | Major topic |
| Friend murine leukemia virus | Major topic |
| Vaccination | Major topic |
| Animals | |
| Antibodies, Neutralizing | |
| Antibodies, Viral | |
| Antigen Presentation | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Cell Line | |
| Female | |
| Genetic Vectors | |
| Humans | |
| Leukemia, Experimental | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| Retroviridae Infections | |
| Tumor Virus Infections | |
| Viral Envelope Proteins | |
| Viral Vaccines |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11238842 | Role of natural killer cells in resistance against friend retrovirus-induced leukemia. | J Virol | 2001 | https://conductscience.org/library/papers/11238842 | PubMed |
| 2 | 2542797 | An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. | Nature | 1989 | https://conductscience.org/library/papers/2542797 | PubMed |
| 3 | 1373205 | Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. | J Virol | 1992 | https://conductscience.org/library/papers/1373205 | PubMed |
| 4 | 8380079 | Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. | J Virol | 1993 | https://conductscience.org/library/papers/8380079 | PubMed |
| 5 | 12072490 | Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. | J Virol | 2002 | https://conductscience.org/library/papers/12072490 | PubMed |
| 6 | 15841217 | Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15841217 | PubMed |
| 7 | 16352628 | Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease. | Int Immunol | 2006 | https://conductscience.org/library/papers/16352628 | PubMed |
| 8 | 1744218 | Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. | J Virol Methods | 1991 | https://conductscience.org/library/papers/1744218 | PubMed |
| 9 | 1465459 | Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1465459 | PubMed |
| 10 | 7687300 | Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. | J Virol | 1993 | https://conductscience.org/library/papers/7687300 | PubMed |
| 11 | 18538453 | Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus. | Vaccine | 2008 | https://conductscience.org/library/papers/18538453 | PubMed |
| 12 | 17150163 | Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion. | Mol Imaging | 2006 | https://conductscience.org/library/papers/17150163 | PubMed |
| 13 | 9689105 | T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9689105 | PubMed |
| 14 | 9705256 | Immunoprotective determinants in friend murine leukemia virus envelope protein. | Virology | 1998 | https://conductscience.org/library/papers/9705256 | PubMed |
| 15 | 8892868 | Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. | J Virol | 1996 | https://conductscience.org/library/papers/8892868 | PubMed |
| 16 | 18160188 | Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies. | Vaccine | 2008 | https://conductscience.org/library/papers/18160188 | PubMed |
| 17 | 11797011 | Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. | Nature | 2002 | https://conductscience.org/library/papers/11797011 | PubMed |
| 18 | 11899087 | Cellular and molecular mechanisms of vaccine-induced protection against retroviral infections. | Curr Mol Med | 2001 | https://conductscience.org/library/papers/11899087 | PubMed |
| 19 | 4430891 | Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex. | J Exp Med | 1974 | https://conductscience.org/library/papers/4430891 | PubMed |
| 20 | 15861131 | A quasi-atomic model of human adenovirus type 5 capsid. | EMBO J | 2005 | https://conductscience.org/library/papers/15861131 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40590260 | Developing the next-generation of adenoviral vector vaccines. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/40590260 | PubMed |
| 33252742 | Structural Organization and Protein-Protein Interactions in Human Adenovirus Capsid. | Subcell Biochem | 2021 | https://conductscience.org/library/papers/33252742 | PubMed |
| 32650622 | Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32650622 | PubMed |
| 31568492 | Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection. | PLoS Pathog | 2019 | https://conductscience.org/library/papers/31568492 | PubMed |
| 31375593 | Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model. | J Virol | 2019 | https://conductscience.org/library/papers/31375593 | PubMed |
| 30049954 | Progress in Adenoviral Capsid-Display Vaccines. | Biomedicines | 2018 | https://conductscience.org/library/papers/30049954 | PubMed |
| 29951052 | Correlates of Follicular Helper Bias in the CD4 T Cell Response to a Retroviral Antigen. | Front Immunol | 2018 | https://conductscience.org/library/papers/29951052 | PubMed |
| 29439476 | Virus-Like-Vaccines against HIV. | Vaccines (Basel) | 2018 | https://conductscience.org/library/papers/29439476 | PubMed |
| 28548059 | Oncolytic Adenoviruses in Cancer Treatment. | Biomedicines | 2014 | https://conductscience.org/library/papers/28548059 | PubMed |
| 28449719 | Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors. | Retrovirology | 2017 | https://conductscience.org/library/papers/28449719 | PubMed |
| 28362809 | Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform. | PLoS One | 2017 | https://conductscience.org/library/papers/28362809 | PubMed |
| 28166802 | Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery. | Retrovirology | 2017 | https://conductscience.org/library/papers/28166802 | PubMed |
| 27806296 | Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus. | Cell Rep | 2016 | https://conductscience.org/library/papers/27806296 | PubMed |
| 27076190 | Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection. | Retrovirology | 2016 | https://conductscience.org/library/papers/27076190 | PubMed |
| 25000983 | Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed. | J Immunol | 2014 | https://conductscience.org/library/papers/25000983 | PubMed |
| 24981329 | The effect of fiber truncations on the stability of adenovirus type 5. | Mol Biotechnol | 2014 | https://conductscience.org/library/papers/24981329 | PubMed |
| 24757514 | The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence. | Ther Adv Vaccines | 2013 | https://conductscience.org/library/papers/24757514 | PubMed |
| 24349306 | Interleukin-encoding adenoviral vectors as genetic adjuvant for vaccination against retroviral infection. | PLoS One | 2013 | https://conductscience.org/library/papers/24349306 | PubMed |
| 23707160 | Prospects for oral replicating adenovirus-vectored vaccines. | Vaccine | 2013 | https://conductscience.org/library/papers/23707160 | PubMed |
| 23560981 | Comparison of polystyrene nanoparticles and UV-inactivated antigen-displaying adenovirus for vaccine delivery in mice. | Virol J | 2013 | https://conductscience.org/library/papers/23560981 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| EMB | 133418 | PubTator's text mining | https://conductscience.org/library/genes/133418 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20007267
GET https://conductscience.org/api/papers/v1/20007267/references?page=2